Neurosurgery Resident @NeurosurgUCSF | MD @UCSFMedicine | Interested in neuro-oncology, gene therapy, synthetic biology, surgical innovation.
- Tweets95
- Following499
- Followers525
- Likes2.2K
ALT Graphic showing a photo of UCSF cerebrovascular neurosurgeon Ethan Winkler, MD, PhD, talking to a medical student during a surgery for the removal of a brain arteriovenous malformation (AVM). Banner says: Neurosurgery Sub-Internship. Text below says: First rotations start in June. Apply Before April 21.
ALT Award graphic showing photos of Manish Aghi, MD, PhD, and Philip Theodosopoulos, MD, who received Excellence in Mentoring and Excellence in Teaching Awards from The Haile T. Debas Academy of Medical Educators at this year's Celebration of New Members ceremony.
ALT Graphic showing the logo of the UCSF Department of Neurological Surgery and headshot photos of the three people who just matched into the UCSF neurosurgery residency program. Text below their photos identifies them as Joseph Oh, MD from UCSF, Robert Osorio, MD, from UCSF, and Joseph Chen, MD, from Brown University.
ALT Graphic showing the logo of the UCSF Department of Neurological Surgery and headshot photos of the three people who just matched into the UCSF neurosurgery residency program. Text below their photos identifies them as Joseph Oh, MD from UCSF, Robert Osorio, MD, from UCSF, and Joseph Chen, MD, from Brown University.
ALT Graphic showing the logo of the UCSF Department of Neurological Surgery and headshot photos of the three people who just matched into the UCSF neurosurgery residency program. Text below their photos identifies them as John Bernabei, MD, PhD, from the University of Pennsylvania; Sravani Kondapavulur, MD, PhD, from the University of California, San Francisco; and Mahmoud Elguindy, MD, PhD, from The University of Texas Southwestern.
ALT Graphic with photos of Alexander Haddad, MD, Manish Aghi, MD, PhD, and Noriyuki Kasahara, MD, PhD that announces them as UCSF Catalyst Awardees. The research project funded is called "Synthetic Novel Replicating Retroviral Gene Therapy Platform for the Treatment of Glioblastoma."